Clinical Breast Cancer

1

Effective Role of Hormonal Therapy in Metastatic Primary Neuroendocrine Breast Carcinoma

Amanpreet Buttar, Kriti Mittal, Ashraf Khan, Venu Bathini

Journal:

Year:

2011

Language:

english

File:

PDF, 3.21 MB

english, 2011

2

Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer

Howard A. Burris III, Jay Tibbitts, Scott N. Holden, Mark X. Sliwkowski, Gail D. Lewis Phillips

Journal:

Clinical Breast Cancer

Year:

2011

Language:

english

File:

PDF, 851 KB

english, 2011

3

ALK-1–Negative Anaplastic Large Cell Lymphoma Associated With Breast Implants: A New Clinical Entity

Davide Lazzeri, Tommaso Agostini, Guido Bocci, Giordano Giannotti, Giovanni Fanelli, Antonio Giuseppe Naccarato, Romano Danesi, Marco Tuccori, Marcello Pantaloni, Carlo D'Aniello

Journal:

Clinical Breast Cancer

Year:

2011

Language:

english

File:

PDF, 1.90 MB

english, 2011

4

Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer

Ayca Gucalp, Joseph A. Sparano, James Caravelli, Jean Santamauro, Sujata Patil, Alyson Abbruzzi, Christine Pellegrino, Jackie Bromberg, Chau Dang, Maria Theodoulou, Joan Massague, Larry Norton, Cliffo

Journal:

Clinical Breast Cancer

Year:

2011

Language:

english

File:

PDF, 477 KB

english, 2011

5

Phase II Study of Neoadjuvant Weekly nab-Paclitaxel and Carboplatin, With Bevacizumab and Trastuzumab, As Treatment For Women With Locally Advanced HER2+ Breast Cancer

Denise A. Yardley, Eric Raefsky, Raul Castillo, Anup Lahiry, Richard LoCicero, Dana Thompson, Mythili Shastry, Howard A. Burris III, John D. Hainsworth

Journal:

Clinical Breast Cancer

Year:

2011

Language:

english

File:

PDF, 370 KB

english, 2011

6

Chylous Fistula After Axillary Lymph Node Dissection: Incidence, Management, and Possible Cause

Mandeep Singh, S.V. Suryanarayana Deo, Nootan Kumar Shukla, Archit Pandit

Journal:

Clinical Breast Cancer

Year:

2011

Language:

english

File:

PDF, 670 KB

english, 2011

7

Prevalence and Prognostic Role of Triple-Negative Breast Cancer by Race: A Surveillance Study

Helen Swede, David I. Gregorio, Susan H. Tannenbaum, Jessica A. Brockmeyer, Christine Ambrosone, Lori L. Wilson, Mellisa A. Pensa, Lou Gonsalves, Richard G. Stevens, Carolyn D. Runowicz

Journal:

Clinical Breast Cancer

Year:

2011

Language:

english

File:

PDF, 514 KB

english, 2011

8

Age and Survival Estimates in Patients Who Have Node-Negative T1ab Breast Cancer by Breast Cancer Subtype

Rachel L. Theriault, Jennifer K. Litton, Elizabeth A. Mittendorf, Huiqin Chen, Funda Meric-Bernstam, Mariana Chavez-MacGregor, Phuong K. Morrow, Wendy A. Woodward, Aysegul Sahin, Gabriel N. Hortobagyi

Journal:

Clinical Breast Cancer

Year:

2011

Language:

english

File:

PDF, 325 KB

english, 2011

9

Recommendation to Revise the AJCC/UICC Breast Cancer Staging System for Inclusion of Proven Prognostic Factors: ER/PR Receptor Status and HER2 neu

Vijayashree Murthy, Ronald S. Chamberlain

Journal:

Clinical Breast Cancer

Year:

2011

Language:

english

File:

PDF, 120 KB

english, 2011

10

Accuracy of Breast Magnetic Resonance Imaging in Predicting Pathologic Response in Patients Treated With Neoadjuvant Chemotherapy

Jennifer De Los Santos, Wanda Bernreuter, Kimberly Keene, Helen Krontiras, John Carpenter, Kirby Bland, Alan Cantor, Andres Forero

Journal:

Clinical Breast Cancer

Year:

2011

Language:

english

File:

PDF, 1015 KB

english, 2011

11

Editorial Board/Masthead

Journal:

Clinical Breast Cancer

Year:

2011

Language:

english

File:

PDF, 68 KB

english, 2011

12

Volume 11; Issue 5

Effective Role of Hormonal Therapy in Metastatic Primary Neuroendocrine Breast Carcinoma

Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer

ALK-1–Negative Anaplastic Large Cell Lymphoma Associated With Breast Implants: A New Clinical Entity

Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer

Phase II Study of Neoadjuvant Weekly nab-Paclitaxel and Carboplatin, With Bevacizumab and Trastuzumab, As Treatment For Women With Locally Advanced HER2+ Breast Cancer

Chylous Fistula After Axillary Lymph Node Dissection: Incidence, Management, and Possible Cause

Prevalence and Prognostic Role of Triple-Negative Breast Cancer by Race: A Surveillance Study

Age and Survival Estimates in Patients Who Have Node-Negative T1ab Breast Cancer by Breast Cancer Subtype

Recommendation to Revise the AJCC/UICC Breast Cancer Staging System for Inclusion of Proven Prognostic Factors: ER/PR Receptor Status and HER2 neu

Accuracy of Breast Magnetic Resonance Imaging in Predicting Pathologic Response in Patients Treated With Neoadjuvant Chemotherapy

Editorial Board/Masthead

Table of Contents